Volume 22, Number 8—August 2016
Dispatch
Use of Unamplified RNA/cDNA–Hybrid Nanopore Sequencing for Rapid Detection and Characterization of RNA Viruses
Table
Virus samples and time points, min |
Top hits (GenBank accession no.) |
LAST score |
Total bases mapped, % |
Coverage, % |
Average base depth |
Per read accuracy, % |
VEEV TC-83 (GenBank accession no. L01443) | ||||||
Viral genomes (RefSeq databases†) | ||||||
15 | VEEV TC-83 (L01443) | 138,321 | 5.54 | 76.14 | 50.94x | 59–80 |
VEEV WT (NC_001449.1) | 789 | 0.05 | 18.59 | 1.76x | 60–78 | |
60 | VEEV TC-83 (L01443) | 419,153 | 17.17 | 78.54 | 153.16x | 57–80 |
VEEV WT (NC_001449.1) | 1,182 | 0.08 | 32.12 | 1.82x | 58–78 | |
Alphavirus genomes | ||||||
15 | VEEV TC-83 (L01443) | 31,320 | 1.13 | 48.92 | 16.21x | 67–69 |
VEEV E541/73 (AF093102.1 | 6,463 | 0.27 | 95.07 | 5.26x | 62–73 | |
VEEV 71–180 (AF069903.1) | 5,865 | 0.22 | 30.18 | 5.08x | 65–73 | |
60 |
VEEV TC-83 (L01443) | 96,348 | 3.55 | 48.92 | 50.84x | 62–74 |
VEEV E541/73 (AF093102.1) | 21,411 | 0.89 | 99.91 | 16.36x | 61–73 | |
VEEV 71–180 (AF069903.1) |
16,429 |
0.64 |
51.04 |
8.78x |
65–73 |
|
EBOV/Mak-C05 (GenBank accession no. KX000400) | ||||||
Viral genomes (RefSeq databases) | ||||||
15 | EBOV/Mak-137 (KX000400) | 529 | 0.11 | 9.29 | 1.00x | 68 |
Bovine herpesvirus (NC_024303.1) | 73 | 0.02 | 0.18 | 1.00x | 67 | |
60 | EBOV/Mak-137 (KX000400) | 2,371 | 0.53 | 22.23 | 2.09x | 66–71 |
Bovine herpesvirus (NC_024303.1) | 239 | 0.04 | 0.27 | 1.58x | 67–74 |
*VEEV, Venezuelan equine encephalitis virus; EBOV, Ebolavirus; LAST (Computational Biology Research Consortium, Tokyo, Japan), multiple sequence alignment program.
†RefSeq, NCBI Reference Sequence Database (http://www.ncbi.nlm.nih.gov/RefSeq/).
Page created: July 15, 2016
Page updated: July 15, 2016
Page reviewed: July 15, 2016
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.